Chordate Medical Holding AB (publ) (CMH.ST)

SEK 12.6

(-1.18%)

Market Cap (In SEK)

13.96 Million

Revenue (In SEK)

976.28 Thousand

Net Income (In SEK)

-29.18 Million

Avg. Volume

1325.00

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
12.2-120.0
PE
-
EPS
-
Beta Value
0.913
ISIN
SE0009495559
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Anders Weilandt
Employee Count
-
Website
https://www.chordate.com
Ipo Date
2022-02-15
Details
Chordate Medical Holding AB (publ), a medical technology company, develops products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It focuses on the ear-nose and throat area. The company was founded in 2005 and is based in Kista, Sweden.